Soy isoflavone supplementation and bone mineral density in menopausal women: A 2-y multicenter clinical trial

American Journal of Clinical Nutrition

Volumn 90, Issue 5, 2009, Pages 1433-1439

  Wong, William W ^a   Lewis, Richard D ^b   Steinberg, Francene M ^c   Murray, Michael J ^d   Cramer, Margaret A ^b   Amato, Paula ^a   Young, Ronald L ^a   Barnes, Stephen ^e   Ellis, Kenneth J ^a   Shypailo, Roman J ^a   Fraley, J Kennard ^a   Konzelmann, Karen L ^a   Fischer, Joan G ^b   Smith, E O'Brian ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Kaiser Foundation Research Institute   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONE; CALCIUM CARBONATE; DAIDZEIN; GENISTEIN; GLYCITEIN; ISOFLAVONE DERIVATIVE; PLACEBO; VITAMIN D;

ADULT; ARTICLE; BODY MASS; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT COMPLIANCE; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT;

ADULT; BETA-GLUCANS; BONE DENSITY; CALCIUM; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; ISOFLAVONES; MIDDLE AGED; PLACEBOS; POSTMENOPAUSE; TIME FACTORS; VITAMIN D;

EID: 70350637278     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.28001     Document Type: Article

References (40)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-795
2. Lafferty FW, Fiske ME. Postmenopausal estrogen replacement: a long-term cohort study. Am J Med 1994;97:66-77. (Pubitemid 24223636)
3. Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women. Ann Intern Med 1995;122:9-16.
4. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogen and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-1593
5. Risch HA, Howe GR. Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage cohort study. Am J Epidemiol 1994; 139:670-683
6. Woodruff JD, Pickar JH. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. Am J Obstet Gynecol 1994;170:1213-1223 (Pubitemid 24188677)
7. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199-208.
8. Brink E, Coxam V, Robins S, Wahala K, Cassidy A, Branca F. Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. Am J Clin Nutr 2008;87:761-770
9. Marini H, Minutoli L, Polito F, et al. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann Intern Med 2007;146:839-847 (Pubitemid 351650484)
10. Chen YM, Ho SC, Lam SS, Ho SS, Woo JL. Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial. Menopause 2004;11:246-254
11. Mazess RB, Barden HS. Bone density in premenopausal women: effects of age, dietary intake, physical activity, smoking, and birth-control pills. Am J Clin Nutr 1991;53:132-142
12. Nguyen TV, Kelly PJ, Sambrook PN, Gilbert C, Pocock NA, Eisman JA. Lifestyle factors and bone density in the elderly: implications for osteoporosis prevention. J Bone Miner Res 1994;9:1339-1346 (Pubitemid 24268844)
13. Egger P, Duggleby S, Hobbs R, Fall C, Cooper C. Cigarette smoking and bone mineral density in the elderly. J Epidemiol Community Health 1996;50:47-50. (Pubitemid 26070635)
14. Modlesky CM, Lewis RD, Yetman KA, et al. Comparison of body composition and bone mineral measurements from two DXA instruments in young men. Am J Clin Nutr 1996;64:669-676
15. Ellis KJ, Shypailo RJ. Bone mineral and body composition measurements: cross-calibration of pencil-beam and fan-beam dual-energy x-ray absorptiometers. J Bone Miner Res 1998;13:1613-1618 (Pubitemid 28465302)
16. Clasey JL, Hartman ML, Kanaley J, et al. Body composition by DEXA in older adults: accuracy and influence of scan mode. Med Sci Sports Exerc 1997;29:560-567 (Pubitemid 27183595)
17. Genant HK, Grampp S, Gluer CC, et al. Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 1994;9:1503-1514 (Pubitemid 24300099)
18. Ellis KJ, Shypailo RS, Steinberg FM, Lewis RD, Young RL, Wong WW. Reproducibility of fan-beam DXA measurements in adults and phantoms. J Clin Densitom 2004;7:413-418
19. Finkelstein JS, Butler JP, Cleary RL, Neer RM. Comparison of four methods for cross-calibrating dual-energy x-ray absorptiometers to eliminate systematic errors when upgrading equipment. J Bone Miner Res 1994;9:1945-1952
20. Wahner HW, Looker A, Dunn WL, Walters LC, Hauser MF, Novak C. Quality control of bone densitometry in a national health survey (NHANES III) using three mobile examination centers. J Bone Miner Res 1994;9:951-960 (Pubitemid 24178078)
21. Kirk P, Patterson RE, Lampe J. Development of a soy food frequency questionnaire to estimate isoflavone consumption in US adults. J Am Diet Assoc 1999;99:558-563 (Pubitemid 29220379)
22. Frankenfeld CL, Patterson RE, Horner NK, et al. Validation of a soy food-frequency questionnaire and evaluation of correlates of plasma isoflavone concentrations in postmenopausal women. Am J Clin Nutr 2003;77:674-680
23. Blair SN. How to assess exercise habits and physical fitness. In: Matarazzo JD, Miller NE, Weiss SM, eds. Behavioral health: a handbook of health enhancement and disease prevention. New York: John Wiley & Sons, 1984:424-447
24. Blair SN, Haskell WL, Ho P, et al. Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol 1985;122:794-804. (Pubitemid 16207346)
25. Sallis JF, Haskell WL, Wood PD, et al. Physical activity assessment methodology in the Five-City Project.AmJ Epidemiol 1985;121:91-106.
26. Field CS, Ory SJ, Wahner HW, Herrmann RR, Judd HL, Riggs BL. Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgerical menopause: a two-year placebo-controlled trial. Am J Obstet Gynecol 1993;168:114-121
27. American Cancer Society. Cancer facts & figures, 2008. Atlanta, GA: American Cancer Society, 2008.
28. Setchell KD, Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 2003;78:593S-609S. (Pubitemid 40012554)
29. Chen YM, Ho SC, Lam SS, Ho SS, Woo JL. Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 2003;88:4740-4747
30. Booth SL, Dallal G, Shea MK, Gundberg C, Peterson JW, Dawson-Hughes B. Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab 2008;93:1217-1223
31. Finkelstein JS, Brockwell SE, Mehta V, et al. Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab 2008;93:861-868
32. Lydeking-Olsen E, Beck-Jensen JE, Setchell KD, Holm-Jensen T. Soymilk or progesterone for prevention of bone loss: a 2 year randomized, placebo-controlled trial. Eur J Nutr 2004;43:246-257 (Pubitemid 39222536)
33. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE, Falconer G, Green CL. Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am J Clin Nutr 1995;61:1140-1145
34. Cranney A, Horsley T, O'Donnell S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 2007:1-235.
35. Dawson-Hughes B, Bischoff-Ferrari HA. Therapy of osteoporosis with calcium and vitamin D. J Bone Miner Res 2007;22(suppl 2):V59-63.
36. Ma DF, Qin LQ, Wang PY, Katoh R. Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials. Clin Nutr 2008;27:57-64. (Pubitemid 351234248)
37. Liu J, Ho SC, Su YX, Chen WQ, Zhang CX, Chen YM. Effect of long-term intervention of soy isoflavones on bone mineral density in women: a meta-analysis of randomized controlled trials. Bone 2009;44: 948-953
38. Zhang X, Shu XO, Li H, et al. Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch Intern Med 2005;165:1890-1895 (Pubitemid 41352084)
39. Mei J, Yeung SS, Kung AW. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 2001;86:5217-5221 (Pubitemid 33070238)
40. Somekawa Y, Chiguchi M, Ishibashi T, Aso T. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 2001;97:109-115 (Pubitemid 32057167)